Login to Your Account



Other News To Note


Thursday, October 6, 2011
Neurocrine Biosciences Inc., of San Diego, said it achieved its second milestone in a collaboration with Abbott, of Abbott Park, Ill., for elagolix and next-generation gonadotropin-releasing hormone receptor antagonists, triggering a $20 million payment.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription